NEW YORK (GenomeWeb News) – Informatics firm Strand Life Sciences announced on Wednesday it has signed a memorandum of understanding focused on translational cancer research with India's Mazumdar Shaw Comprehensive Cancer Centre of the Narayana Hrudalaya.
Specifically, the partnership includes joint research and training in translational cancer using genomics and proteomics.
The partners have begun a pilot project studying head and neck cancer, one of the most prevalent types of cancer in India, Strand said in a statement. According to Binay Panda, senior vice president of Strand and head of Ganit Labs — a state of the art functional genomics and next-generation sequencing center in Bangalore, India — the collaboration brings together for the first time in that country scientists from fields as diverse as computer science, head and neck surgery, and genome biology for comprehensive research work.
Strand, which has offices in Bangalore and San Francisco, is a participant in the public-private initiative to create Ganit Labs.
Terms of the deal were not disclosed.